Search research articles
Contact Us
Filters
Showing results (1-10 of 97) with videos related to
Page
of 10
Sort By:
Frontiers in Medicine
|
May 25, 2017
Periostin and Discoidin Domain Receptor 1: New Biomarkers or Targets for Therapy of Renal Disease
Niki Prakoura, Christos Chatziantoniou
Cellular and Molecular Life Sciences : CMLS
|
September 9, 2017
Periostin in kidney diseases
Niki Prakoura, Christos Chatziantoniou
Matrix Biology : Journal of the International Society for Matrix Biology
|
January 3, 2018
Renal fibrosis: Recent translational aspects
Hélène François, Christos Chatziantoniou
Journal of the American Society of Nephrology : JASN
|
May 29, 2026
Discovering New Therapies for Kidney Fibrosis: The Promise of Epigenetic and Epitranscriptomic Modulation
Lilia Abbad, Christos Chatziantoniou
Kidney International
|
July 25, 2008
Matrix metalloproteinases and matrix receptors in progression and reversal of kidney disease: therapeutic perspectives
Pierre Ronco, Christos Chatziantoniou
Current Opinion in Nephrology and Hypertension
|
December 20, 2007
Is kidney injury a reversible process?
Christos Chatziantoniou, Jean-Claude Dussaule
Bulletin De L'Academie Nationale De Medecine
|
February 26, 2009
[Reversal of renal fibrosis: lessons from experimental models]
Jean-Claude Dussaule, Christos Chatziantoniou
American Journal of Physiology. Renal Physiology
|
July 12, 2005
Insights into the mechanisms of renal fibrosis: is it possible to achieve regression?
Christos Chatziantoniou, Jean-Claude Dussaule
Chest
|
September 16, 2005
Cervical mediastinoscopy and anterior mediastinotomy in superior vena cava obstruction
Theodosios Dosios, Nikolaos Theakos, Christos Chatziantoniou
Nature Reviews. Nephrology
|
February 11, 2025
Advances and challenges in kidney fibrosis therapeutics
Lilia Abbad, Emmanuel Esteve, Christos Chatziantoniou
Page
of 10
Search research articles
Search
Showing results (1-10 of 97) with videos related to
Sort By:
Page
of 10
Frontiers in Medicine
|
May 25, 2017
Periostin and Discoidin Domain Receptor 1: New Biomarkers or Targets for Therapy of Renal Disease
Niki Prakoura, Christos Chatziantoniou
Cellular and Molecular Life Sciences : CMLS
|
September 9, 2017
Periostin in kidney diseases
Niki Prakoura, Christos Chatziantoniou
Matrix Biology : Journal of the International Society for Matrix Biology
|
January 3, 2018
Renal fibrosis: Recent translational aspects
Hélène François, Christos Chatziantoniou
Journal of the American Society of Nephrology : JASN
|
May 29, 2026
Discovering New Therapies for Kidney Fibrosis: The Promise of Epigenetic and Epitranscriptomic Modulation
Lilia Abbad, Christos Chatziantoniou
Kidney International
|
July 25, 2008
Matrix metalloproteinases and matrix receptors in progression and reversal of kidney disease: therapeutic perspectives
Pierre Ronco, Christos Chatziantoniou
Current Opinion in Nephrology and Hypertension
|
December 20, 2007
Is kidney injury a reversible process?
Christos Chatziantoniou, Jean-Claude Dussaule
Bulletin De L'Academie Nationale De Medecine
|
February 26, 2009
[Reversal of renal fibrosis: lessons from experimental models]
Jean-Claude Dussaule, Christos Chatziantoniou
American Journal of Physiology. Renal Physiology
|
July 12, 2005
Insights into the mechanisms of renal fibrosis: is it possible to achieve regression?
Christos Chatziantoniou, Jean-Claude Dussaule
Chest
|
September 16, 2005
Cervical mediastinoscopy and anterior mediastinotomy in superior vena cava obstruction
Theodosios Dosios, Nikolaos Theakos, Christos Chatziantoniou
Nature Reviews. Nephrology
|
February 11, 2025
Advances and challenges in kidney fibrosis therapeutics
Lilia Abbad, Emmanuel Esteve, Christos Chatziantoniou
Page
of 10